trending Market Intelligence /marketintelligence/en/news-insights/trending/ck_sxzozgnl9obceuzbz7q2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Scythian Biosciences extends letter of intent to buy medical cannabis company

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Scythian Biosciences extends letter of intent to buy medical cannabis company

Scythian Biosciences Corp. said it extended the previously announced letter of intent to buy MMJ International Investments Inc., a company pursuing medical cannabis opportunities in South America.

The companies now have until April 30 to negotiate a definitive deal, as opposed to March 31 previously.

Scythian, a Canadian medical cannabis company, added that its COO David Schrader will step down on March 31.